Elsevier

Clinics in Dermatology

Volume 23, Issue 1, January–February 2005, Pages 6-14
Clinics in Dermatology

Inherited defects in keratins

https://doi.org/10.1016/j.clindermatol.2004.09.014Get rights and content

Abstract

In the years following the initial reports of keratin gene mutations in epidermolysis bullosa simplex, great strides have been made in understanding the basic biology of human keratins and in understanding the etiology and pathogenesis of a number of specific human single gene disorders. A total of 19 human keratin genes is now linked to specific diseases. This article summarizes current knowledge in relation to basic keratin biology, known disease associations, and genotype correlation in this diverse and complex group of conditions.

Section snippets

Keratins: basic biology

The cytoplasm of animal cells is structured by scaffolding composed of actin microfilaments, microtubules, and intermediate filaments. The largest group within the intermediate filament family is the keratins (types I and II intermediate filament proteins), which are expressed specifically in the cytoplasm of epithelial cells where they form a dense meshwork of 10-nm filaments (Fig. 1).1 In 1977, work on sheep wool keratins had suggested a classification of keratins into 2 subtypes. This

Genetic disorders due to mutations in human keratins

Since 1991, mutations in several keratin genes have been found to cause a variety of human diseases affecting the epidermis and other epithelial structures (Table 1). Epidermolysis bullosa simplex (EBS) was the first keratin disease to be identified with mutations in both the K5 and K14 genes rendering basal epidermal keratinocytes less resilient to trauma and resulting in skin fragility.7., 8., 9. Since mutations were identified in the basal cell keratins, the total number of keratin genes

References (51)

  • A. Ishida-Yamamoto et al.

    Selective involvement of keratins K1 and K10 in the cytoskeletal abnormality of epidermolytic hyperkeratosis (bullous congenital ichthyosiform erythroderma)

    J. Invest. Dermatol.

    (1992)
  • V.P. Sybert et al.

    Cyclic ichthyosis with epidermolytic hyperkeratosis: a phenotype conferred by mutations in the 2B domain of keratin K1

    Am. J. Hum. Genet.

    (1999)
  • V. Kimonis et al.

    A mutation in the V1 end domain of keratin 1 in non-epidermolytic palmar-plantar keratoderma

    J. Invest. Dermatol.

    (1994)
  • N.V. Whittock et al.

    Frameshift mutation in the V2 domain of human keratin 1 results in striate palmoplantar keratoderma

    J. Invest. Dermatol.

    (2002)
  • E. Sprecher et al.

    Evidence for novel functions of the keratin tail emerging from a mutation causing ichthyosis hystrix

    J. Invest. Dermatol.

    (2001)
  • S.J. Hatsell et al.

    Novel splice site mutation in keratin 1 underlies mild epidermolytic palmoplantar keratoderma in three kindreds

    J. Invest. Dermatol.

    (2001)
  • A. Terron-Kwiatkowski et al.

    Two cases of primarily palmoplantar keratoderma associated with novel mutations in keratin 1

    J. Invest. Dermatol.

    (2002)
  • S.P. Covello et al.

    Mutations in keratin K9 in kindreds with epidermolytic palmoplantar keratoderma and epidemiology in Northern Ireland

    J. Invest. Dermatol.

    (1998)
  • W.H. McLean et al.

    Ichthyosis bullosa of Siemens—a disease involving keratin 2e

    J. Invest. Dermatol.

    (1994)
  • A. Terrinoni et al.

    A mutation in the V1 domain of K16 is responsible for unilateral palmoplantar verrucous nevus

    J. Invest. Dermatol.

    (2000)
  • P.A. Coulombe et al.

    ‘Hard’ and ‘soft’ principles defining the structure, function and regulation of keratin intermediate filaments

    Curr. Opin. Cell Biol.

    (2002)
  • R.A. Quinlan et al.

    Intermediate filaments

  • E.B. Lane

    Keratins

  • A.D. Irvine et al.

    Human keratin diseases: the increasing spectrum of disease and specificity of genotype-phenotype correlation

    Br. J. Dermatol.

    (1999)
  • L. Langbein et al.

    K6irs1, K6irs2, K6irs3, and K6irs4 represent the inner-root-sheath–specific type II epithelial keratins of the human hair follicle

    J. Invest. Dermatol.

    (2003)
  • Cited by (15)

    • KRT14 haploinsufficiency results in increased susceptibility of keratinocytes to TNF-α-induced apoptosis and causes Naegeli-Franceschetti- Jadassohn syndrome

      2008, Journal of Investigative Dermatology
      Citation Excerpt :

      Mutations in KRT14 have previously been shown to underlie a different inherited disorder, epidermolysis bullosa simplex (EBS; MIM 131800, 131760, 131900). Indeed, more than 60 autosomal dominant and recessive mutations in KRT14 (http://www.interfil.org) have been reported in this skin fragility disorder, which is characterized by blistering of the skin following mechanical trauma (Irvine, 2005). In contrast to NFJS, loss of dermatoglyphics has never been reported in EBS, and abnormal pigmentation has been limited to a rare EBS subtype (EBS with mottled pigmentation) (Uttam et al., 1996; Horiguchi et al., 2005; Harel et al., 2006).

    • Epidermolysis Bullosa

      2008, Neonatal Dermatology
    • Dyskeratosis as a histologic feature in epidermolysis bullosa simplex-Dowling Meara

      2007, Journal of the American Academy of Dermatology
      Citation Excerpt :

      Both diseases are also characterized histologically by various degrees of dyskeratosis.8,9,20 In contrast with diseases of the desmosomal plaque,21 abnormal organization of the cell cytoskeleton in EBS-DM and other keratin diseases is the direct consequence of dominant mutations affecting the structure and function of keratin molecules.6 Although rare keratin mutations have been shown to cause cutaneous disorders resulting from haplo-insufficiency,22 in most cases these mutations exert a so-called dominant negative effect, with mutant molecules interfering with the function of wild type keratins and leading to destabilization of the keratin filament network resulting in filament aggregation and clumping.23

    • Medical Genetics and Genomics: Questions for Board Review

      2022, Medical Genetics and Genomics: Questions for Board Review
    View all citing articles on Scopus
    View full text